Beta Bionics, Inc. BBNX
Set alert
16.75 USD -0.83 -4.72%
At close · Oct 30
15.09 -1.66 -9.94%
After hours · Oct 30, 7:15 PM ET
16.59 Day range 17.59
8.86 52-week range 31.99
- YTD
- -45.03%
- 1 year
- -37.45%
- Open
- 17.30
- Prev close
- 17.58
- Mkt cap
- 910.65M
- Vol
- 1.07M
- Avg vol
- 1.30M
- EPS
- -1.83
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 16.59
- High
- 17.59
- Forward P/E
- -9.90
- Beta
- 0.00
- Short ratio
- 4.12
- Inst. own
- 112.90%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Feb 16, 2027
- 50-d avg
- 19.16
- 200-d avg
- 14.81
- 1y target
- 24.24
MAX chart
Events in this range
- Oct 28, 2025Earnings: -0.33; estimate -0.45; surprise 26.67%
- Feb 17, 2026Earnings: -0.3; estimate -0.42; surprise 28.57%
- Apr 21, 2026Earnings: -0.49; estimate -0.53; surprise 7.55%
- Jul 29, 2026Earnings: -0.53; estimate -0.58103; surprise 8.78%
- Sep 15, 2026Rating: Baird · Neutral → Neutral
- Sep 15, 2026Rating: Truist Securities · Buy → Buy
- Sep 15, 2026Rating: B of A Securities · Neutral → Neutral
- Sep 23, 2026Rating: Wells Fargo · — → Overweight
- Sep 24, 2026Rating: Truist Securities · Buy → Buy
- Oct 12, 2026Rating: Jefferies · — → Buy
- Oct 27, 2026Earnings: -0.52; estimate -0.52334; surprise 0.64%
Signals (136)
| Name | Date | Ago |
|---|---|---|
| MACD: Sell Signal | Oct 30, 2026 | 2 days ago |
| SMA: Bearish | Oct 28, 2026 | 4 days ago |
| SMA: Bearish | Oct 28, 2026 | 4 days ago |
| SMA: Bullish | Oct 26, 2026 | 6 days ago |
| SMA: Bearish | Oct 23, 2026 | 1 week ago |
| SMA: Bullish | Oct 22, 2026 | 1 week ago |
| MACD: Buy Signal | Oct 22, 2026 | 1 week ago |
| SMA: Bullish | Oct 20, 2026 | 1 week ago |
| SMA: Bearish | Sep 29, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 29, 2026 | 1 month ago |
| SMA: Bearish | Sep 28, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 17, 2026 | 1 month ago |
| SMA: Bullish | Sep 15, 2026 | 1 month ago |
| SMA: Bullish | Sep 15, 2026 | 1 month ago |
| SMA: Bearish | Sep 9, 2026 | 1 month ago |
| SMA: Bearish | Sep 4, 2026 | 1 month ago |
| SMA: Bullish | Sep 3, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 2, 2026 | 2 months ago |
| SMA: Bearish | Sep 1, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 11, 2026 | 2 months ago |
| SMA: Bullish | Aug 10, 2026 | 2 months ago |
| SMA: Bullish | Aug 7, 2026 | 2 months ago |
| RSI: Oversold | Jul 31, 2026 | 3 months ago |
| SMA: Bearish | Jul 28, 2026 | 3 months ago |
| SMA: Bullish | Jul 27, 2026 | 3 months ago |
| SMA: Bearish | Jul 24, 2026 | 3 months ago |
| SMA: Bearish | Jul 22, 2026 | 3 months ago |
| SMA: Bullish | Jul 10, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 9, 2026 | 3 months ago |
| SMA: Bearish | Jul 8, 2026 | 3 months ago |
| MACD: Buy Signal | Jun 25, 2026 | 4 months ago |
| RSI: Overbought | Jun 25, 2026 | 4 months ago |
| SMA: Bullish | Jun 24, 2026 | 4 months ago |
| MACD: Sell Signal | Jun 18, 2026 | 4 months ago |
| SMA: Bearish | Jun 16, 2026 | 4 months ago |
| RSI: Overbought | Jun 11, 2026 | 4 months ago |
| RSI: Overbought | Jun 4, 2026 | 5 months ago |
| SMA: Bullish | May 22, 2026 | 5 months ago |
| MACD: Buy Signal | May 21, 2026 | 5 months ago |
| SMA: Bullish | May 20, 2026 | 5 months ago |
| SMA: Bearish | May 8, 2026 | 5 months ago |
| SMA: Bullish | May 6, 2026 | 5 months ago |
| MACD: Sell Signal | Apr 28, 2026 | 6 months ago |
| SMA: Bearish | Apr 27, 2026 | 6 months ago |
| SMA: Bearish | Apr 23, 2026 | 6 months ago |
| SMA: Bullish | Apr 13, 2026 | 6 months ago |
| SMA: Bullish | Apr 13, 2026 | 6 months ago |
| RSI: Oversold | Apr 10, 2026 | 6 months ago |
| SMA: Bearish | Mar 27, 2026 | 7 months ago |
| SMA: Bullish | Mar 19, 2026 | 7 months ago |
| RSI: Oversold | Feb 27, 2026 | 8 months ago |
| SMA: Bearish | Feb 18, 2026 | 8 months ago |
| SMA: Bullish | Feb 13, 2026 | 8 months ago |
| SMA: Bearish | Feb 12, 2026 | 8 months ago |
| SMA: Bullish | Feb 10, 2026 | 8 months ago |
| MACD: Buy Signal | Feb 5, 2026 | 8 months ago |
| SMA: Bearish | Jan 9, 2026 | 9 months ago |
| SMA: Bearish | Jan 9, 2026 | 9 months ago |
| RSI: Oversold | Jan 9, 2026 | 9 months ago |
| SMA: Bullish | Jan 6, 2026 | 9 months ago |
| SMA: Bullish | Jan 6, 2026 | 9 months ago |
| SMA: Bearish | Jan 2, 2026 | 10 months ago |
| SMA: Bearish | Dec 31, 2025 | 10 months ago |
| MACD: Sell Signal | Dec 31, 2025 | 10 months ago |
| MACD: Buy Signal | Dec 24, 2025 | 10 months ago |
| SMA: Bullish | Dec 19, 2025 | 10 months ago |
| SMA: Bearish | Dec 17, 2025 | 10 months ago |
| SMA: Bullish | Dec 12, 2025 | 10 months ago |
| SMA: Bearish | Dec 4, 2025 | 11 months ago |
| SMA: Bullish | Dec 3, 2025 | 11 months ago |
| MACD: Sell Signal | Dec 2, 2025 | 11 months ago |
| SMA: Bearish | Dec 1, 2025 | 11 months ago |
| MACD: Buy Signal | Nov 21, 2025 | 11 months ago |
| RSI: Overbought | Nov 21, 2025 | 11 months ago |
| MACD: Sell Signal | Nov 17, 2025 | 11 months ago |
| SMA: Bullish | Nov 14, 2025 | 11 months ago |
| SMA: Bearish | Nov 13, 2025 | 11 months ago |
| SMA: Bullish | Nov 7, 2025 | 11 months ago |
| SMA: Bearish | Nov 6, 2025 | 12 months ago |
| RSI: Overbought | Oct 29, 2025 | 1 year ago |
| SMA: Bullish | Oct 27, 2025 | 1 year ago |
| SMA: Bullish | Oct 27, 2025 | 1 year ago |
| MACD: Buy Signal | Oct 27, 2025 | 1 year ago |
| SMA: Bearish | Oct 23, 2025 | 1 year ago |
| SMA: Bullish | Oct 22, 2025 | 1 year ago |
| SMA: Bearish | Oct 15, 2025 | 1 year ago |
| SMA: Bearish | Oct 15, 2025 | 1 year ago |
| SMA: Bullish | Oct 14, 2025 | 1 year ago |
| SMA: Bullish | Oct 13, 2025 | 1 year ago |
| SMA: Bearish | Oct 10, 2025 | 1 year ago |
| SMA: Bearish | Oct 10, 2025 | 1 year ago |
| SMA: Bullish | Oct 3, 2025 | 1 year ago |
| SMA: Bullish | Oct 3, 2025 | 1 year ago |
| SMA: Bearish | Sep 26, 2025 | 1 year ago |
| MACD: Sell Signal | Sep 19, 2025 | 1 year ago |
| SMA: Bearish | Sep 16, 2025 | 1 year ago |
| RSI: Overbought | Sep 4, 2025 | 1 year ago |
| SMA: Bullish | Aug 21, 2025 | 1 year ago |
| SMA: Bearish | Aug 20, 2025 | 1 year ago |
| SMA: Bullish | Aug 14, 2025 | 1 year ago |
| MACD: Buy Signal | Aug 14, 2025 | 1 year ago |
| SMA: Bullish | Aug 13, 2025 | 1 year ago |
| SMA: Bearish | Aug 11, 2025 | 1 year ago |
| MACD: Sell Signal | Aug 11, 2025 | 1 year ago |
| SMA: Bearish | Aug 6, 2025 | 1 year ago |
| SMA: Bullish | Jul 29, 2025 | 1 year ago |
| MACD: Buy Signal | Jul 21, 2025 | 1 year ago |
| SMA: Bullish | Jul 17, 2025 | 1 year ago |
| SMA: Bearish | Jun 23, 2025 | 1 year ago |
| SMA: Bearish | Jun 17, 2025 | 1 year ago |
| MACD: Sell Signal | Jun 17, 2025 | 1 year ago |
| SMA: Bullish | Jun 16, 2025 | 1 year ago |
| SMA: Bearish | Jun 13, 2025 | 1 year ago |
| RSI: Overbought | Jun 4, 2025 | 1 year ago |
| RSI: Overbought | Jun 2, 2025 | 1 year ago |
| SMA: Bullish | May 29, 2025 | 1 year ago |
| SMA: Bearish | May 28, 2025 | 1 year ago |
| SMA: Bullish | May 27, 2025 | 1 year ago |
| SMA: Bearish | May 23, 2025 | 1 year ago |
| SMA: Bullish | May 15, 2025 | 1 year ago |
| SMA: Bearish | May 14, 2025 | 1 year ago |
| SMA: Bullish | May 2, 2025 | 1 year ago |
| SMA: Bullish | Apr 24, 2025 | 1 year ago |
| SMA: Bearish | Apr 21, 2025 | 1 year ago |
| SMA: Bullish | Apr 16, 2025 | 1 year ago |
| SMA: Bearish | Apr 10, 2025 | 1 year ago |
| SMA: Bullish | Apr 9, 2025 | 1 year ago |
| MACD: Buy Signal | Apr 9, 2025 | 1 year ago |
| RSI: Oversold | Apr 3, 2025 | 1 year ago |
| MACD: Sell Signal | Mar 28, 2025 | 1 year ago |
| RSI: Oversold | Mar 26, 2025 | 1 year ago |
| SMA: Bearish | Mar 21, 2025 | 1 year ago |
| SMA: Bullish | Mar 17, 2025 | 1 year ago |
| SMA: Bearish | Mar 4, 2025 | 1 year ago |
| RSI: Oversold | Mar 4, 2025 | 1 year ago |
| SMA: Bullish | Feb 28, 2025 | 1 year ago |
Key statistics
- Market cap
- 1.15B
- Enterprise value
- 748.76M
- Trailing P/E
- 0.00
- Forward P/E
- -9.90
- PEG ratio
- 0.00
- Price / sales
- 9.70
- Price / book
- 3.75
- EPS (TTM)
- -1.76
- Beta
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- -61.31%
- Revenue (TTM)
- 119.01M
- Revenue growth
- 37.80%
- Free cash flow
- -40.29M
- Total cash
- 180.49M
- Total debt
- 6.51M
- Return on equity
- -26.16%
- Shares outstanding
- 53.95M
- Short % of float
- 11.25%
- 50-day average
- 19.16
- 200-day average
- 14.81
Analyst view
Consensus: none
Price target (mean) 24.24 +44.7% upside
Now 16.75
- Target (low)
- 16.00
- Target (mean)
- 24.24
- Target (high)
- 30.40
Ratings (0m) 15 11 buy · 4 hold · 0 sell
- Strong buy2
- Buy9
- Hold4
- Sell0
- Strong sell0
Next earnings
Feb 16, 2027
Expected Feb 16, 2027. Consensus EPS estimate -0.51333.
Financials — quick view
BBNX Revenue — quarterly 35.51M
BBNX Net income — quarterly -24.35M
BBNX EPS — quarterly -0.52
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Feb 16, 2027 | Dec 30, 2026 | -0.49 | — | — | — |
| Oct 27, 2026 | Sep 30, 2026 | -0.52334 | -0.52 | 0.00 | +0.64% |
| Jul 29, 2026 | Jun 30, 2026 | -0.58103 | -0.53 | +0.05 | +8.78% |
| Apr 21, 2026 | Mar 31, 2026 | -0.53 | -0.49 | +0.04 | +7.55% |
| Feb 17, 2026 | Dec 31, 2025 | -0.42 | -0.30 | +0.12 | +28.57% |
| Oct 28, 2025 | Sep 30, 2025 | -0.45 | -0.33 | +0.12 | +26.67% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 12, 2026 | Jefferies | init | — | Buy |
| Sep 24, 2026 | Truist Securities | main | Buy | Buy |
| Sep 23, 2026 | Wells Fargo | init | — | Overweight |
| Sep 15, 2026 | B of A Securities | main | Neutral | Neutral |
| Sep 15, 2026 | Truist Securities | reit | Buy | Buy |
| Sep 15, 2026 | Baird | main | Neutral | Neutral |
About Beta Bionics, Inc.
Beta Bionics, Inc., a commercial-stage medical device company, engages in the design, development, and commercialization of solutions to enhance the health and quality of life of insulin-requiring people with diabetes. It offers iLet Bionic Pancreas, an insulin delivery device for the treatment of type 1 diabetes in adults and children six years of age and older. The company is also developing Patch Pump, an insulin pump that is designed to adhere directly to the skin and administer insulin without the need for tubing; Bihormonal iLet, which combines automated delivery of insulin and glucagon; and iLet to treat people with insulin-dependent type-2 diabetes. It has collaboration and license agreement with Xeris Pharmaceuticals, Inc. (Xeris) to develop and commercialize a pump-compatible glucagon formulation; and development and commercialization agreement with Abbott Diabetes Care Inc. to develop and commercialize an automated insulin delivery system. The company was incorporated in 2015 and is headquartered in Irvine, California.
- Sector
- Healthcare
- Industry
- Medical Devices
- Country
- United States
- Website
- betabionics.com
News
- Bronstein, Gewirtz & Grossman LLC Urges Beta Bionics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
- BBNX DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Beta Bionics (BBNX) Investors of Securities Class Action Lawsuit Deadline on November 3, 2026
- BBNX FINAL DEADLINE: ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Beta Bionics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important November 3 Deadline in Securities Class Action - BBNX
- BBNX DEADLINE TUESDAY: Bragar Eagel & Squire, P.C. Reminds Beta Bionics, Inc. Investors They Have Until November 3rd to Seek Lead Plaintiff Role with the Firm
- Beta Bionics 96 Hour Deadline Alert: Kahn Swick & Foti, LLC Reminds Investors With Losses In Excess Of $100,000 of Deadline in Class Action Lawsuit Against Beta Bionics, Inc. - BBNX
- BBNX FINAL DEADLINE: ROSEN, REGARDED INVESTOR RIGHTS COUNSEL, Encourages Beta Bionics, Inc. Investors to Secure Counsel Before Important November 3 Deadline in Securities Class Action - BBNX
- BBNX SHAREHOLDER NOTICE: Beta Bionics Investors with Substantial Losses Have Opportunity to Lead Securities Class Action
- Kaplan Fox Alerts Investors of Beta Bionics, Inc. (NASDAQ: BBNX) to an Upcoming Deadline of November 3, 2026 in the Securities Class Action
- BBNX CLASS ACTION NOTICE: Faruqi & Faruqi, LLP Reminds Beta Bionics (BBNX) Investors of Securities Class Action Lawsuit Deadline on November 3, 2026
- CLASS ACTION DEADLINE APPROACHING: Berger Montague Advises Beta Bionics, Inc. (BBNX) Investors to Inquire About a Securities Fraud Class Action by November 3, 2026
Your note
Sign in to keep a note on BBNX — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| CARNEY SEAN D | Director | Stock Award(Grant) | May 20, 2026 | 32,209 |
| DEAREN DANNY L | Director | Stock Award(Grant) | May 20, 2026 | 32,209 |
| FEIDER STEPHEN | Chief Financial Officer | Sale | Sep 1, 2026 | 159,378 |
| HOPMAN MARK | Officer | Sale | Sep 30, 2026 | 56,109 |
| MENSINGER MIKE | Officer | Sale | Sep 15, 2026 | 177,390 |
| MICHEL GERARD J | Director | Stock Award(Grant) | May 20, 2026 | 33,509 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Eventide Asset Management LLC | 13.90% | 6,253,673 | 133.77M | Jun 29, 2026 |
| Soleus Capital Management, L.P. | 9.77% | 4,393,714 | 93.98M | Jun 29, 2026 |
| Morgan Stanley | 9.48% | 4,266,822 | 91.27M | Jun 29, 2026 |
| Sands Capital Alternatives, LLC | 8.24% | 3,708,043 | 79.32M | Jun 29, 2026 |
| Blackrock Inc. | 7.42% | 3,340,171 | 71.45M | Jun 29, 2026 |
| Point72 Asset Management, L.P. | 5.01% | 2,254,683 | 48.23M | Jun 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| MUTUAL FUND SERIES TRUST-Eventide Gilead Fund | 8.86% | 3,983,917 | 85.22M | Jun 29, 2026 |
| MUTUAL FUND SERIES TRUST-Eventide Healthcare & Life Sciences Fund | 4.56% | 2,052,176 | 43.90M | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 2.83% | 1,272,504 | 27.22M | Jun 29, 2026 |
| iShares Trust-iShares Russell 2000 ETF | 2.35% | 1,055,217 | 22.57M | Sep 29, 2026 |
| Bruce Fund, Inc.-BRUCE FUND | 1.48% | 665,700 | 14.24M | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 1.04% | 469,615 | 10.05M | Jun 29, 2026 |